Dr. Jason Gallagher Offers Insight to Verywell Health on the FDA’s Emergency Use Authorization of Tocilizumab for Patients Hospitalized with COVID-19

Jason Gallagher, PharmD, FCCP, FIDP, FIDSA, BCPS, Clinical Professor and Director of the Postgraduate Year Two Infectious Diseases Residency at the Temple University School of Pharmacy and Clinical Pharmacy Specialist in Infectious Diseases at Temple University Hospital, offered insight to Verywell Health about the U.S. Food and Drug Administration’s recent emergency use authorization of tocilizumab (Actemra) for patients who are hospitalized with COVID-19 and in what instances it is best utilized.